Cleveland Clinic Anthracycline-Induced Heart Failure Risk Calculator

Cleveland Clinic Anthracycline-Induced Heart Failure Risk Calculator: Explanation and Clinical Context This tool estimates the risk of developing heart failure following anthracycline chemotherapy based on key clinical factors. It incorporates the cumulative dose of doxorubicin, patient age, and the presence of hypertension, diabetes mellitus, and smoking history. A higher risk score indicates a greater likelihood of cardiotoxicity, guiding clinicians in monitoring and preventive strategies.